Results 161 to 170 of about 51,336 (238)

Proactive Brain Screening Using Contrast-Enhanced Brain CT Scans in HER2+ Metastatic Breast Cancer. [PDF]

Clin Cancer Res
Griguolo G, Bottosso M, Landa G, Bonomi G, Miglietta F, Guarascio MC, La Commare M, Zanghì F, Sheppard T, Giorgi CA, Falci C, Hodgdon C, Caumo F, Dieci MV, Guarneri V.   +14 more
europepmc   +1 more source

Triple‐Negative Breast Cancer Cells Utilize IL8 and CXCL1 to Suppress NK Cells’ Function and Facilitate Cancer Metastasis

Advanced Science, Volume 13, Issue 44, 7 August 2026.
Triple‐negative breast cancer (TNBC) cells evade natural killer (NK) cell immunity by secreting IL8 and CXCL1. These chemokines suppress NK cells’ function via CXCR1/2 and enhance cancer cells’ survival through PD‐L1 upregulation and BCL‐2 anti‐apoptotic signaling.
Mingheng Yuan, Hongmei Yang, Renfei Wu, Meng Hao, Xiangpeng Chu, Chuxia Deng, Kathy Qian Luo   +6 more
wiley   +1 more source

PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set. [PDF]

Acta Oncol
Drakenberg Danese MB, Vannas CP, Fagman HA, Karlsson PO, Larsson KF.   +4 more
europepmc   +1 more source

Smallholder Fish Farmers’ Preferences for Climate‐Smart Aquaculture Practices in Kakamega County, Kenya: A Latent Class Approach

Aquaculture, Fish and Fisheries, Volume 6, Issue 4, August 2026.
ABSTRACT Aquaculture, identified as a critical sector to bridge the fish supply gap, remains extensively vulnerable to the vagaries of climate change. In efforts to achieve a “triple win” effect on increased productivity, enhanced resilience and reduced emissions, climate‐smart aquaculture (CSAq) practices have been developed for implementation ...
Boke Christopher Magesi, Hillary Kiplangat Bett, Augustus Sammy Muluvi   +2 more
wiley   +1 more source

Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis. [PDF]

J Clin Med
Deutschmann C, Heinzl F, Leser C, Gschwantler-Kaulich D, Singer CF, Kostic S, Golescu A, Pfeiler G.   +7 more
europepmc   +1 more source

Structural Modifications of Nonsteroidal Anti‐Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery

Archiv der Pharmazie, Volume 359, Issue 8, August 2026.
This review provides a comprehensive analysis of the molecular modifications applied to NSAIDs to develop novel antimicrobial agents. By focusing on structural changes and their impact on biological activity, the study highlights innovative strategies to combat the global challenge of antimicrobial resistance.
Ebru Koçak Aslan, Ayşe Karagüzel, Miyase Gözde Gündüz   +2 more
wiley   +1 more source

Technical and biological sources of noise confound multiplexed enhancer AAV screening. [PDF]

Nat Commun
Hunker AC, Mich JK, Taskin N, Torkelson A, Cardenas T, Lalanne JB, Mahoney JT, Bertagnolli D, Chakka AB, Chakrabarty R, Donadio NP, Ferrer R, Gasperini M, Goldy J, Guzman J, Jin K, Khem S, Kutsal R, Martinez RA, Newman D, Pena N, Rimorin C, Rocha D, Shapovalova NV, Tieu M, Weed N, Zhou T, Hodge R, Yao S, Shendure J, Smith KA, Lein ES, Tasic B, Levi BP, Ting JT.   +34 more
europepmc   +1 more source

Evaluation of a Product Intended for Microbiological Control in Animal Production, and Its Combination With Halquinol

Animal Research and One Health, Volume 4, Issue 3, Page 302-313, August 2026.
Activo Liquid and Halquinol inhibit Salmonella and Escherichia coli in culture media. Activo Liquid exhibits bactericidal action, whereas HA is bacteriostatic, and their combination results in positive or indifferent interactions. This combination effectively inhibits E. coli throughout digestion simulation, thus reducing the required concentrations of
Alberto Gonçalves Evangelista, Lucas dos Santos Janotto, Adriana Paula Possamai, Carolina Cini Perry, Francine Lemes Ribeiro, Rafael Canonenco de Araujo, Fernando Bittencourt Luciano   +6 more
wiley   +1 more source

Psychological Adjustment to Metastatic Cancer: A Comparative Longitudinal Analysis of Breast vs. Lung Cancer Patients. [PDF]

Healthcare (Basel)
Saveljic M, Roganovic M, Muzurovic E, Sutalo N, Mamic M, Plestina S.   +5 more
europepmc   +1 more source

Low‐Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer

Cancer Innovation, Volume 5, Issue 4, August 2026.
Antiangiogenic‐based regimens demonstrated superior efficacy compared to chemotherapy alone in heavily pretreated MBC patients, with manageable AEs. ABSTRACT Background The prognosis for metastatic breast cancer (MBC) remains poor, and treatment options are limited for patients with heavily pretreated disease. Although antiangiogenic agents may provide
Yuanyi Wang, Yalong Qi, Cheng Zeng, Ruixia Song, Yuhan Wei, Haili Qian, Fei Ma   +6 more
wiley   +1 more source